If you are still having problems viewing this message, please click here for additional help.


Volume 32, Issue 6 (June 2018)

In this issue
Review Article
Also new

Review Article

Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents

Herve Avet-Loiseau & Thierry Facon

Leukemia 2018 32 :1267 - 1276; March 28, 2018; 10.1038/s41375-018-0098-9


Abstract | Full Text

Management of patients with acute promyelocytic leukemia

Sabine Kayser, Richard F. Schlenk & Uwe Platzbecker

Leukemia 2018 32 :1277 - 1294; April 24, 2018; 10.1038/s41375-018-0139-4


Abstract | Full Text

Targeting MYC in multiple myeloma

K. K. Jovanović, C. Roche-Lestienne, I. M. Ghobrial, T. Facon, B. Quesnel et al.

Leukemia 2018 32 :1295 - 1306; February 22, 2018; 10.1038/s41375-018-0036-x


Abstract | Full Text


Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatments

Paolo Ghia & Andy Rawstron

Leukemia 2018 32 :1307 - 1316; March 26, 2018; 10.1038/s41375-018-0109-x


Abstract | Full Text


Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia

Jessica C. Petrov, Masayuki Wada, Kevin G. Pinz, Lulu E. Yan, Kevin H. Chen et al.

Leukemia 2018 32 :1317 - 1326; February 25, 2018; 10.1038/s41375-018-0075-3


Abstract | Full Text

A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies

Daichi Inoue, Takeshi Fujino, Paul Sheridan, Yao-zhong Zhang, Reina Nagase et al.

Leukemia 2018 32 :1327 - 1337; March 03, 2018; 10.1038/s41375-018-0083-3


Abstract | Full Text

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies

Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, James S. Blachly, Christopher J. Walker et al.

Leukemia 2018 32 :1338 - 1348; February 25, 2018; 10.1038/s41375-018-0068-2


Abstract | Full Text

Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin

Vincent-Philippe Lavallée, Jalila Chagraoui, Tara MacRae, Miriam Marquis, Arnaud Bonnefoy et al.

Leukemia 2018 32 :1349 - 1357; February 23, 2018; 10.1038/s41375-018-0069-1


Abstract | Full Text

Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia

Jolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, Ellen Geerdens, Heidi Segers et al.

Leukemia 2018 32 :1358 - 1369; April 18, 2018; 10.1038/s41375-018-0127-8


Abstract | Full Text

Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)

Sumit Gupta, Meenakshi Devidas, Mignon L. Loh, Elizabeth A. Raetz, Si Chen et al.

Leukemia 2018 32 :1370 - 1379; February 23, 2018; 10.1038/s41375-018-0039-7


Abstract | Full Text

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Reinhard Stauder, Ge Yu, Karin A. Koinig, Tim Bagguley, Pierre Fenaux et al.

Leukemia 2018 32 :1380 - 1392; March 06, 2018; 10.1038/s41375-018-0089-x


Abstract | Full Text

Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation

Aleš Hnízda, Milan Fábry, Takaya Moriyama, Petr Pachl, Michael Kugler et al.

Leukemia 2018 32 :1393 - 1403; February 25, 2018; 10.1038/s41375-018-0073-5


Abstract | Full Text

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial

Charles Dumontet, Cyrille Hulin, Meletios A. Dimopoulos, Andrew Belch, Angela Dispenzieri et al.

Leukemia 2018 32 :1404 - 1413; April 26, 2018; 10.1038/s41375-018-0133-x


Abstract | Full Text

Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset

Gaurav Goyal, Adam C. Bartley, Shealeigh Funni, Jonathan Inselman, Nilay D. Shah et al.

Leukemia 2018 32 :1414 - 1420; March 21, 2018; 10.1038/s41375-018-0099-8


Abstract | Full Text

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

Surbhi Sidana, Nidhi Tandon, Angela Dispenzieri, Morie A. Gertz, David Dingli et al.

Leukemia 2018 32 :1421 - 1426; February 21, 2018; 10.1038/s41375-018-0063-7


Abstract | Full Text

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, Ma Teresa Cibeira, Laura Magnano et al.

Leukemia 2018 32 :1427 - 1434; February 02, 2018; 10.1038/s41375-018-0013-4


Abstract | Full Text

Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis

Tom Verbiest, Rosemary Finnon, Natalie Brown, Lourdes Cruz-Garcia, Paul Finnon et al.

Leukemia 2018 32 :1435 - 1444; March 03, 2018; 10.1038/s41375-018-0085-1


Abstract | Full Text

Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR

Laura Notario, Elisenda Alari-Pahissa, Almudena Albentosa, Magdalena Leiva, Guadalupe Sabio et al.

Leukemia 2018 32 :1445 - 1457; February 27, 2018; 10.1038/s41375-018-0052-x


Abstract | Full Text

Utx loss causes myeloid transformation

Liting Zheng, Longyong Xu, Qing Xu, Lu Yu, Danfeng Zhao et al.

Leukemia 2018 32 :1458 - 1465; February 02, 2018; 10.1038/s41375-018-0011-6


Abstract | Full Text

Structural basis of DUX4/IGH-driven transactivation

Xue Dong, Weina Zhang, Haiyan Wu, Jinyan Huang, Ming Zhang et al.

Leukemia 2018 32 :1466 - 1476; March 15, 2018; 10.1038/s41375-018-0093-1


Abstract | Full Text


Revisiting thrombocytopenia in acute promyelocytic leukemia

Florian Kuchenbauer & Christian Buske

Leukemia 2018 32 :1477 - 1478; March 23, 2018; 10.1038/s41375-018-0105-1


Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature